NCT06484439View on ClinicalTrials.gov

Controlled Trial to Determine Most Effective Post-Operative Analgesia After Third Molar Extraction

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

February 14, 2018

Primary Completion Date

November 3, 2021

Study Completion Date

December 1, 2021

Conditions
Pain, Post-operativeThird MolarOral SurgeryPain, Acute
Interventions
DRUG

Ketorolac

10 mg PO q 6h scheduled

DRUG

Oxycodone

5 mg PO PRN

DRUG

Acetaminophen

650 mg q 6h scheduled

DRUG

Ibuprofen

600 mg PO scheduled q6h

DRUG

Hydrocodone

5 mg hydrocodone PO PRN q6h

Trial Locations (1)

92134

Naval Medical Center San Diego, San Diego

All Listed Sponsors
lead

United States Naval Medical Center, San Diego

FED

NCT06484439 - Controlled Trial to Determine Most Effective Post-Operative Analgesia After Third Molar Extraction | Biotech Hunter | Biotech Hunter